|Articles|August 15, 2012

ResearchNurses.co Signs Contract to Support MS Studies in UK

ResearchNurses.co, a UK-based research nurses provider, has been awarded a contract with Nottingham University Hospitals Research and Innovation Department to provide research nursing services for clinical trials related to multiple sclerosis (MS).

As part of the project, research nurses will work alongside three major pharmaceutical sponsors as well as the MS Society in clinical trials for patients with relapsing-remitting MS and secondary progressive MS.

ResearchNurses.co will be working with some of the country’s leading neurologist consultants and investigators at the hospital including Professor Chris Constantinescu, Dr Bruno Gran and Dr Nikos Evangelou.

Dr Maria Koufali, Deputy Director for Research & Innovation at Nottingham University Hospitals said: “These studies are of huge importance to everyone affected by multiple sclerosis  and we are keen to offer them to as many patients as possible. This will ensure patient access to innovative medicines but also improvement of our MS clinical services.
“ResearchNurses.co have been extremely quick and efficient at responding to our needs and have demonstrated that they are able to provide a wide-ranging and reliable service, helping us to ensure the integrity of our trial data as well as ensuring trial participants are comfortable throughout the study.”

Based at Nottingham’s Queens Medical Center, ResearchNurses.co will liaise with key sponsors and investigators to oversee and provide drug infusions and venepuncture, as well as providing processing and monitoring services.

John Illingworth, managing director of ResearchNurses.co added: “Many of our clients require nursing assistance and on-site support, our research nurses have extensive experience in fitting into existing team structures as well as expert knowledge of key protocols allowing them to provide a tailor made service and additional resource where it matters most.


Related to this article

The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
What the Epilepsy Community Has Taught Us About Trial Feasibility
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, shares what she has learned firsthand from families living with Dravet syndrome and CDKL5 deficiency disorder about what makes trial participation possible—and what makes it not.